Propofol post-conditioning protects against cardiomyocyte apoptosis in hypoxia/reoxygenation injury by suppressing nuclear factor-kappa B translocation via extracellular signal-regulated kinase mitogen-activated protein kinase pathway
- 1 July 2011
- journal article
- basic science
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Anaesthesiology
- Vol. 28 (7), 525-534
- https://doi.org/10.1097/eja.0b013e32834296d5
Abstract
Background and objective Perioperative myocardial ischaemia leads to an exceedingly high mortality. Previous studies have indicated that propofol pre-conditioning could mimic the cardioprotective effects of ischaemic pre-conditioning. The purpose of this study was to determine whether propofol post-conditioning is cardioprotective and to explore the possible molecular mechanism of propofol post-conditioning. Methods Primary cultured neonatal rat cardiomyocytes were exposed to 12 h of hypoxia followed by 4 h of reoxygenation (H/R) and post-conditioned by different concentrations of propofol at the onset of reperfusion with and without a specific inhibitor of extracellular signal-regulated kinases (ERKs). Cell apoptosis and the generation of intracellular reactive oxygen species were measured using FACScalibur flow cytometric analysis. ERK1/2 phosphorylation and nuclear factor-kappa B (NF-κB) translocation were determined by western blot and immunofluorescence, respectively. Results Propofol post-conditioning enhanced cell viability (86.6 ± 6.5 versus 64.1 ± 3.4%) and reduced apoptosis (3.6 ± 0.4 versus 12.5 ± 2.1%) to protect cardiomyocytes against H/R injury. Meanwhile, propofol post-conditioning stimulated expression of phosphor-ERKs. H/R markedly induced p65 NF-κB nuclear translocation in cardiomyocytes, whereas propofol post-conditioning significantly suppressed H/R-primed NF-κB translocation. Moreover, addition of the mitogen-activated protein kinase kinase 1 inhibitor U0126 into cardiomyocytes 30 min before H/R eliminated the cardioprotection of propofol post-conditioning. Conclusion Propofol exerts cardioprotection when administered at the early phase of reperfusion. The effect is mediated through decrease in cardiomyocyte apoptosis and NF-κB nucleus translocation potentially via ERK signalling pathways.Keywords
This publication has 31 references indexed in Scilit:
- The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in ratsBrain Research, 2009
- Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition poreJournal of Zhejiang University-SCIENCE B, 2008
- Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotectionHeart Failure Reviews, 2007
- PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioningCardiovascular Research, 2006
- Myocardial protection in reperfusion with postconditioningExpert Review of Cardiovascular Therapy, 2005
- Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2American Journal of Physiology-Heart and Circulatory Physiology, 2005
- Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt PathwayCirculation Research, 2004
- NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NOJournal of Molecular and Cellular Cardiology, 2004
- Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioningAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.Circulation, 1986